Tesamorelin + Ipamorelin – Research-Grade Dual Peptide Blend
This formulation combines two structurally distinct synthetic peptides: a growth hormone–releasing hormone (GHRH) analog and a short growth hormone–releasing peptide (GHRP) analog. Each component is independently synthesized and analytically characterized prior to combination into a defined dual-peptide research construct.
In laboratory research environments, this blend is utilized as a reference system for studying multi-pathway peptide interaction models, comparative receptor-binding dynamics, and structure–function relationships associated with long-chain and short-chain peptide analogs. The defined composition enables controlled investigation of peptide stability and interaction behavior under in vitro conditions.
Unlike complex biologics or full-length endogenous proteins, this dual peptide construct represents a precisely manufactured research formulation suitable for mechanistic assays and exploratory biochemical studies. This material is intended strictly for laboratory research use only and is not designed for human or veterinary application.
Related research compounds
All peptide blends ·Tesamorelin · Ipamorelin · CJC-1295 (w/o DAC) + Ipamorelin (Blend) · Tesamorelin + CJC w/o DAC + Ipamorelin Blend · Sermorelin
Documentation and methods
Analytical testing · How to read a COA · Batch COAs · Storage and handling · What are research peptides



